SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-011618
Filing Date
2022-05-10
Accepted
2022-05-10 09:06:27
Documents
87
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q urgn20220331_10q.htm   iXBRL 10-Q 1449556
2 EXHIBIT 10.1 ex_371898.htm EX-10.1 1080935
3 EXHIBIT 10.2 ex_372863.htm EX-10.2 241574
4 EXHIBIT 31.1 ex_355349.htm EX-31.1 17005
5 EXHIBIT 31.2 ex_355350.htm EX-31.2 16990
6 EXHIBIT 32.1 ex_355351.htm EX-32.1 6663
7 EXHIBIT 32.2 ex_355352.htm EX-32.2 6656
  Complete submission text file 0001437749-22-011618.txt   7578586

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA urgn-20220331.xsd EX-101.SCH 68068
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20220331_cal.xml EX-101.CAL 45118
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20220331_def.xml EX-101.DEF 365554
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20220331_lab.xml EX-101.LAB 311203
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20220331_pre.xml EX-101.PRE 402610
81 EXTRACTED XBRL INSTANCE DOCUMENT urgn20220331_10q_htm.xml XML 773615
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 22907591
SIC: 2834 Pharmaceutical Preparations